AI assistant
Sending…
Solana Co — Director's Dealing 2022
Feb 18, 2022
32724_dirs_2022-02-18_993ae21d-fdfe-48e1-9972-785652655f9b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT)
CIK: 0001610853
Period of Report: 2022-02-16
Reporting Person: MATHIESEN JEFFREY S (CFO and Treasurer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-02-16 | Class A Common Stock | A | 8011 | $0.00 | Acquired | 11948 | Direct |
Footnotes
F1: Grant to the Reporting Person of a stock award under the Issuer's 2018 Omnibus Incentive Plan.
More from Solana Co
Regulatory Filings
2026
May 22
Proxy Solicitation & Information Statement
2026
May 15
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 15
Regulatory Filings
2026
Apr 27
Regulatory Filings
2026
Apr 27
Annual Report
2026
Apr 14
Regulatory Filings
2026
Apr 13
Regulatory Filings
2026
Apr 9
Regulatory Filings
2026
Mar 31